{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:35:42Z","timestamp":1794324942377,"version":"4.9.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007313","name":"The University of Texas MD Anderson Cancer Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The JANE KOSKINAS TED GIOVANIS FOUNDATION FOR HEALTH AND POLICY"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,4,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cancer is a systemic disease with most deaths attributed to metastatic burden. Primary and metastatic tumors, albeit at different anatomic locations, are interconnected through multiple biological processes. Pre-clinical and clinical observations of growth acceleration of metastases after surgery, or abscopal effects outside the radiation field are widely reported, yet reliably triggering favorable and avoiding unfavorable systemic responses remains an unmet clinical need. Understanding local and systemic tumor interaction dynamics will help guide future treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyze the data of multiple in vivo tumor models. We formalize the systemic interplay of tumors as mathematical differential equation and calibrate parameters for each cell line and mouse type. Using model selection metrics, we identify classic tumor growth models with a novel shared carrying capacity parsimoniously describe the pan-cancer experimental data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Shared systemic carrying capacity, metastatic spread potential, and metastatic growth rates differ across tested cell lines and mouse strains. Bi-directional concomitant systemic interconnectivity explains the observed metastatic explosion after primary tumor surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Future investigations should reproduce this analysis in clinical settings and evaluate whether this shared carrying capacity model could help stratify patients at risk of metastatic disease below clinical detectability and inform strategies to control oligometastatic cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-025-03306-9","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:53:11Z","timestamp":1771955591000},"page":"1138-1149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Gompertz growth with a shared carrying capacity optimally simulates primary and metastatic tumor growth dynamics"],"prefix":"10.1038","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9619-728X","authenticated-orcid":false,"given":"Pirmin","family":"Schlicke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preethi","family":"Korangath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5611-2699","authenticated-orcid":false,"given":"Caner","family":"Ercan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Gabrielson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndsey","family":"Werhane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8556-4707","authenticated-orcid":false,"given":"Yinyin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3749-8637","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Benzekry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ivkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9696-6410","authenticated-orcid":false,"given":"Heiko","family":"Enderling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"3306_CR1","first-page":"455","volume":"13","author":"GF Brunton","year":"1980","unstructured":"Brunton GF, Wheldon TE. The Gompertz equation and the construction of tumour growth curves. Cell Tissue Kinet. 1980;13:455\u201360.","journal-title":"Cell Tissue Kinet"},{"key":"3306_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-015-0465-x","volume":"10","author":"S Prokopiou","year":"2015","unstructured":"Prokopiou S, Moros EG, Poleszczuk J, Caudell J, Torres-Roca JF, Latifi K, et al. A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation. Radiat Oncol. 2015;10:159.","journal-title":"Radiat Oncol"},{"key":"3306_CR3","doi-asserted-by":"publisher","first-page":"e1007178","DOI":"10.1371\/journal.pcbi.1007178","volume":"16","author":"C Vaghi","year":"2020","unstructured":"Vaghi C, Rodallec A, Fanciullino R, Ciccolini J, Mochel JP, Mastri M, et al. Population modeling of tumor growth curves and the reduced Gompertz model improve prediction of the age of experimental tumors. PLoS Comput Biol. 2020;16:e1007178.","journal-title":"PLoS Comput Biol"},{"key":"3306_CR4","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.cell.2024.02.009","volume":"187","author":"C Swanton","year":"2024","unstructured":"Swanton C, Bernard E, Abbosh C, Andre F, Auwerx J, Balmain A, et al. Embracing cancer complexity: hallmarks of systemic disease. Cell. 2024;187:1589\u2013616.","journal-title":"Cell"},{"key":"3306_CR5","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1126\/science.1203543","volume":"331","author":"CL Chaffer","year":"2011","unstructured":"Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011;331:1559\u201364.","journal-title":"Science"},{"key":"3306_CR6","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nrclinonc.2011.88","volume":"8","author":"SC Morgan","year":"2011","unstructured":"Morgan SC, Parker CC. Local treatment of metastatic cancer-killing the seed or disturbing the soil? Nat Rev Clin Oncol. 2011;8:504\u20136.","journal-title":"Nat Rev Clin Oncol"},{"key":"3306_CR7","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2174\/156800910791517163","volume":"10","author":"C Raimondi","year":"2010","unstructured":"Raimondi C, Naso G, Gradilone A, Gianni W, Cortesi E, Gazzaniga P. Circulating tumor cells in cancer therapy: are we off target? Current Cancer Drug Targets. 2010;10:509\u201318.","journal-title":"Current Cancer Drug Targets"},{"key":"3306_CR8","doi-asserted-by":"crossref","unstructured":"Lemons JM, Drazer MW, Luke JJ, Chmura SJ. SBRT and the treatment of oligometastatic disease. In: Advances in radiation oncology. Springer; 2017. p. 21\u201339.","DOI":"10.1007\/978-3-319-53235-6_2"},{"key":"3306_CR9","first-page":"871","volume":"42","author":"P Ehrlich","year":"1905","unstructured":"Ehrlich P, Apolant H. Beobachtungen \u00fcber maligne M\u00e4usetumoren. Berliner klinische Wochenschrift. 1905;42:871\u20134.","journal-title":"Berliner klinische Wochenschrift"},{"key":"3306_CR10","first-page":"205","volume":"3","author":"P Ehrlich","year":"1906","unstructured":"Ehrlich P. Experimentelle Karzinomstudien an M\u00e4usen. Zeitschrift f\u00fcr \u00e4rztliche Fortbildung. 1906;3:205\u201313.","journal-title":"Zeitschrift f\u00fcr \u00e4rztliche Fortbildung"},{"key":"3306_CR11","doi-asserted-by":"crossref","unstructured":"Gueron G, Anselmino N, Chiarella P, Ortiz EG, Vickers SL, Paez AV, et al. Game-changing restraint of Ros-damaged phenylalanine, upon tumor metastasis. Cell Death Dis. 2018;9:140.","DOI":"10.1038\/s41419-017-0147-8"},{"key":"3306_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1098\/rspb.1907.0014","volume":"79","author":"EF Bashford","year":"1907","unstructured":"Bashford EF, Murray JA, Cramer W. The natural and induced resistance of mice to the growth of cancer. P R Soc Lond B Conta. 1907;79:164\u201387.","journal-title":"P R Soc Lond B Conta"},{"key":"3306_CR13","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1084\/jem.20041130","volume":"200","author":"MJ Turk","year":"2004","unstructured":"Turk MJ, Guevara-Pati\u00f1o JA, Rizzuto GA, Engelhorn ME, Houghton AN. Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J Exp Med. 2004;200:771\u201382.","journal-title":"J Exp Med"},{"key":"3306_CR14","doi-asserted-by":"publisher","first-page":"6095","DOI":"10.4049\/jimmunol.0803829","volume":"182","author":"Y-C Lin","year":"2009","unstructured":"Lin Y-C, Chang L-Y, Huang C-T, Peng H-M, Dutta A, Chen T-C, et al. Effector\/Memory but not naive regulatory T cells are responsible for the loss of concomitant tumor immunity. J Immunol. 2009;182:6095\u2013104.","journal-title":"J Immunol"},{"key":"3306_CR15","doi-asserted-by":"crossref","unstructured":"Janssen LME, Ramsay EE, Logsdon CD, Overwijk WW. The immune system in cancer metastasis: friend or foe? J Immunother Cancer. 2017;5:79.","DOI":"10.1186\/s40425-017-0283-9"},{"key":"3306_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.canlet.2012.05.021","volume":"324","author":"P Chiarella","year":"2012","unstructured":"Chiarella P, Bruzzo J, Meiss RP, Ruggiero RA. Concomitant tumor resistance. Cancer Lett. 2012;324:133\u201341.","journal-title":"Cancer Lett"},{"key":"3306_CR17","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1158\/0008-5472.CAN-11-2964","volume":"72","author":"RA Ruggiero","year":"2012","unstructured":"Ruggiero RA, Bruzzo J, Chiarella P, Bustuoabad OD, Meiss RP, Pasqualini CD. Concomitant tumor resistance: the role of tyrosine isomers in the mechanisms of metastases control. Cancer Res. 2012;72:1043\u201350.","journal-title":"Cancer Res"},{"key":"3306_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/ijc.2910410317","volume":"41","author":"RD Bonfil","year":"1988","unstructured":"Bonfil RD, Ruggiero RA, Bustuoabad OD, Meiss RP, Pasqualini CD. Role of concomitant resistance in the development of murine lung metastases. Int J Cancer. 1988;41:415\u201322.","journal-title":"Int J Cancer"},{"key":"3306_CR19","first-page":"1073","volume":"6","author":"P Di Gianni","year":"1999","unstructured":"Di Gianni P, Franco M, Meiss RP, Vanzulli S, Piazzon I, Pasqualini CD, et al. Inhibition of metastases by a serum factor associated to concomitant resistance induced by unrelated murine tumors. Oncol Rep. 1999;6:1073\u201384.","journal-title":"Oncol Rep"},{"key":"3306_CR20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s10555-013-9449-1","volume":"33","author":"CM Galmarini","year":"2013","unstructured":"Galmarini CM, Tredan O, Galmarini FC. Concomitant resistance and early-breast cancer: should we change treatment strategies? Cancer Metastasis Rev. 2013;33:271\u201383.","journal-title":"Cancer Metastasis Rev"},{"key":"3306_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jpedsurg.2003.11.029","volume":"39","author":"C Streck","year":"2004","unstructured":"Streck C, Zhang Y, Zhou J, Ng CY, Davidoff A. Endostatin-mediated concomitant resistance in neuroblastoma. J Pediatr Surg. 2004;39:405\u201311.","journal-title":"J Pediatr Surg"},{"key":"3306_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.18383\/j.tom.2016.00151","volume":"2","author":"AM Hamilton","year":"2016","unstructured":"Hamilton AM, Parkins KM, Murrell DH, Ronald JA, Foster PJ. Investigating the Impact of a primary tumor on metastasis and dormancy using MRI: new insights into the mechanism of concomitant tumor resistance. Tomography. 2016;2:79\u201384.","journal-title":"Tomography"},{"key":"3306_CR23","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/annonc\/mdn386","volume":"19","author":"R Demicheli","year":"2008","unstructured":"Demicheli R, Retsky MW, Hrushesky WJ, Baum M, Gukas ID. The effects of surgery on tumor growth: a century of investigations. Ann Oncol. 2008;19:1821\u20138.","journal-title":"Ann Oncol"},{"key":"3306_CR24","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2174\/09298673113209990225","volume":"21","author":"S Romano","year":"2014","unstructured":"Romano S, D\u2019Angelillo A, Romano A, Nappo G, Romano MF. Cellular and molecular background underlying the diversity in therapeutic responses between primary tumours and metastases. Curr Med Chem. 2014;21:1631\u20138.","journal-title":"Curr Med Chem"},{"key":"3306_CR25","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/jnci\/djs629","volume":"105","author":"SC Formenti","year":"2013","unstructured":"Formenti SC, Demaria S. Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst. 2013;105:256\u201365.","journal-title":"J Natl Cancer Inst"},{"key":"3306_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.critrevonc.2014.05.006","volume":"92","author":"C Moncharmont","year":"2014","unstructured":"Moncharmont C, Levy A, Guy JB, Falk AT, Guilbert M, Trone JC, et al. Radiation-enhanced cell migration\/invasion process: a review. Crit Rev Oncol Hematol. 2014;92:133\u201342.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3306_CR27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10585-017-9867-5","volume":"35","author":"BJ Blyth","year":"2018","unstructured":"Blyth BJ, Cole AJ, MacManus MP, Martin OA. Radiation therapy-induced metastasis: radiobiology and clinical implications. Clin Exp Metastasis. 2018;35:223\u201336.","journal-title":"Clin Exp Metastasis"},{"key":"3306_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s10020-018-0015-8","volume":"24","author":"N Sundahl","year":"2018","unstructured":"Sundahl N, Duprez F, Ost P, De Neve W, Mareel M. Effects of radiation on the metastatic process. Mol Med. 2018;24:16.","journal-title":"Mol Med"},{"key":"3306_CR29","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.copbio.2020.08.001","volume":"65","author":"M Ochoa de Olza","year":"2020","unstructured":"Ochoa de Olza M, Bourhis J, Irving M, Coukos G, Herrera FG. High versus low dose irradiation for tumor immune reprogramming. Curr Opin Biotechnol. 2020;65:268\u201383.","journal-title":"Curr Opin Biotechnol"},{"key":"3306_CR30","doi-asserted-by":"crossref","unstructured":"van Schie P, Huisman RG, Wiersma T, Knegjens JL, Navran A, Brandsma D, et al. Local control and toxicity after stereotactic radiotherapy in brain metastases patients and the impact of novel systemic treatments. Radiother Oncol. 2024;200:110540.","DOI":"10.1016\/j.radonc.2024.110540"},{"key":"3306_CR31","doi-asserted-by":"crossref","unstructured":"Ghaffari Laleh N, Loeffler CML, Grajek J, Sta\u0148kov\u00e1 K, Pearson AT, Muti HS, et al. Classical mathematical models for prediction of response to chemotherapy and immunotherapy. PLoS Comput Biol. 2022;18:e1009822.","DOI":"10.1371\/journal.pcbi.1009822"},{"key":"3306_CR32","doi-asserted-by":"crossref","unstructured":"Benzekry S, Lamont C, Beheshti A, Tracz A, Ebos JML, Hlatky L, et al. Classical mathematical models for description and prediction of experimental tumor growth. PLoS Comput Biol. 2014;10:e1003800.","DOI":"10.1371\/journal.pcbi.1003800"},{"key":"3306_CR33","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1158\/0008-5472.CAN-12-4355","volume":"73","author":"P Gerlee","year":"2013","unstructured":"Gerlee P. The model muddle: in search of tumor growth laws. Cancer Research. 2013;73:2407\u201311.","journal-title":"Cancer Research"},{"key":"3306_CR34","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00285-012-0565-2","volume":"67","author":"D Diego","year":"2013","unstructured":"Diego D, Calvo GF, Perez-Garcia VM. Modeling the connection between primary and metastatic tumors. J Math Biol. 2013;67:657\u201392.","journal-title":"J Math Biol"},{"key":"3306_CR35","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1158\/0008-5472.CAN-17-0564","volume":"77","author":"S Benzekry","year":"2017","unstructured":"Benzekry S, Lamont C, Barbolosi D, Hlatky L, Hahnfeldt P. Mathematical modeling of tumor-tumor distant interactions supports a systemic control of tumor growth. Cancer Res. 2017;77:5183\u201393.","journal-title":"Cancer Res"},{"key":"3306_CR36","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/01.shk.0000142249.08135.e9","volume":"22","author":"H Watanabe","year":"2004","unstructured":"Watanabe H, Numata K, Ito T, Takagi K, Matsukawa A. Innate immune response in Th1- and Th2-dominant mouse strains. Shock. 2004;22:460\u20136.","journal-title":"Shock"},{"key":"3306_CR37","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00262-004-0653-2","volume":"54","author":"KL Knutson","year":"2005","unstructured":"Knutson KL, Disis ML. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunol Immunother. 2005;54:721\u20138.","journal-title":"Cancer Immunol Immunother"},{"key":"3306_CR38","doi-asserted-by":"publisher","first-page":"10509","DOI":"10.1021\/acsnano.3c12064","volume":"18","author":"P Korangath","year":"2024","unstructured":"Korangath P, Jin L, Yang CT, Healy S, Guo X, Ke S, et al. Iron oxide nanoparticles inhibit tumor progression and suppress lung metastases in mouse models of breast cancer. ACS Nano. 2024;18:10509\u201326.","journal-title":"ACS Nano"},{"key":"3306_CR39","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1158\/1538-7445.AM2025-2426","volume":"85","author":"X Pan","year":"2025","unstructured":"Pan X, Salvatierra ME, Ercan C, Kakarala L, Lu W, Shi O, et al. Abstract 2426: TMEseg: Connecting histopathology with spatial transcriptomics through tumor microenvironment segmentation for lung cancer. Cancer Res. 2025;85:2426.","journal-title":"Cancer Res"},{"key":"3306_CR40","unstructured":"Xie E, Wang W, Yu Z, Anandkumar A, Alvarez JM, Luo P. SegFormer: simple and efficient design for semantic segmentation with transformers. In Proceedings of the 35th international conference on neural information processing systems: Curran Associates Inc.; 2024."},{"key":"3306_CR41","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1093\/bioinformatics\/btz083","volume":"35","author":"M Amgad","year":"2019","unstructured":"Amgad M, Elfandy H, Hussein H, Atteya LA, Elsebaie MAT, Abo Elnasr LS, et al. Structured crowdsourcing enables convolutional segmentation of histology images. Bioinformatics. 2019;35:3461\u20137.","journal-title":"Bioinformatics"},{"key":"3306_CR42","doi-asserted-by":"publisher","unstructured":"Han C, Pan X, Yan L, Lin H, Li B, Yao S, et al. WSSS4LUAD: grand challenge on weakly-supervised tissue semantic segmentation for lung adenocarcinoma. 2022 Preprint at https:\/\/doi.org\/10.48550\/arXiv.2204.06455.","DOI":"10.48550\/arXiv.2204.06455"},{"key":"3306_CR43","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1006\/jtbi.2000.1075","volume":"203","author":"K Iwata","year":"2000","unstructured":"Iwata K, Kawasaki K, Shigesada N. A dynamical model for the growth and size distribution of multiple metastatic tumors. J Theor Biol. 2000;203:177\u201386.","journal-title":"J Theor Biol"},{"key":"3306_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12976-021-00142-1","volume":"18","author":"P Schlicke","year":"2021","unstructured":"Schlicke P, Kuttler C, Schumann C. How mathematical modeling could contribute to the quantification of metastatic tumor burden under therapy: insights in immunotherapeutic treatment of non-small cell lung cancer. Theor Biol Med Model. 2021;18:11.","journal-title":"Theor Biol Med Model"},{"key":"3306_CR45","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/jso.2930600216","volume":"60","author":"JS Spratt","year":"2006","unstructured":"Spratt JS, Meyer JS, Spratt JA. Rates of growth of human solid neoplasms: Part I. J Surg Oncol. 2006;60:137\u201346.","journal-title":"J Surg Oncol"},{"key":"3306_CR46","doi-asserted-by":"crossref","unstructured":"Sprent P, Smeeton NC. Applied nonparametric statistical methods. 4th ed. New York: CRC Press; 2016.","DOI":"10.1201\/b15842"},{"key":"3306_CR47","doi-asserted-by":"crossref","unstructured":"Schwarz G. Estimating the dimension of a model. Ann Stat. 1978;6:461\u20134.","DOI":"10.1214\/aos\/1176344136"},{"key":"3306_CR48","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/wics.199","volume":"4","author":"AA Neath","year":"2011","unstructured":"Neath AA, Cavanaugh JE. The Bayesian information criterion: background, derivation, and applications. WIREs Comput Stat. 2011;4:199\u2013203.","journal-title":"WIREs Comput Stat"},{"key":"3306_CR49","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s00432-010-0818-7","volume":"136","author":"J Bruzzo","year":"2010","unstructured":"Bruzzo J, Chiarella P, Meiss RP, Ruggiero RA. Biphasic effect of a primary tumor on the growth of secondary tumor implants. J Cancer Res Clin Oncol. 2010;136:1605\u201315.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3306_CR50","doi-asserted-by":"crossref","unstructured":"Voutouri C, Mpekris F, Papageorgis P, Odysseos AD, Stylianopoulos T. Role of constitutive behavior and tumor-host mechanical interactions in the state of stress and growth of solid tumors. PLoS ONE. 2014;9:e104717.","DOI":"10.1371\/journal.pone.0104717"},{"key":"3306_CR51","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/ijc.28572","volume":"135","author":"F Marcucci","year":"2014","unstructured":"Marcucci F, Bellone M, Caserta CA, Corti A. Pushing tumor cells towards a malignant phenotype: stimuli from the microenvironment, intercellular communications and alternative roads. Int J Cancer. 2014;135:1265\u201376.","journal-title":"Int J Cancer"},{"key":"3306_CR52","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nrc2621","volume":"9","author":"B Psaila","year":"2009","unstructured":"Psaila B, Lyden D. The metastatic niche: adapting the foreign soil. Nat Rev Cancer. 2009;9:285\u201393.","journal-title":"Nat Rev Cancer"},{"key":"3306_CR53","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10585-023-10245-3","volume":"41","author":"S Benzekry","year":"2024","unstructured":"Benzekry S, Schlicke P, Mogenet A, Greillier L, Tomasini P, Simon E. Computational markers for personalized prediction of outcomes in non-small cell lung cancer patients with brain metastases. Clin Exp Metastasis. 2024;41:55\u201368.","journal-title":"Clin Exp Metastasis"},{"key":"3306_CR54","first-page":"161","volume":"11","author":"GF Brunton","year":"1978","unstructured":"Brunton GF, Wheldon TE. Characteristic species dependent growth patterns of mammalian neoplasms. Cell Tissue Kinet. 1978;11:161\u201375.","journal-title":"Cell Tissue Kinet"},{"key":"3306_CR55","first-page":"451","volume":"13","author":"GG Steel","year":"1980","unstructured":"Steel GG. Species-dependent growth patterns for mammalian neoplasms. Cell Tissue Kinet. 1980;13:451\u20133.","journal-title":"Cell Tissue Kinet"},{"key":"3306_CR56","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/01.sla.0000197712.71055.12","volume":"243","author":"JC Coffey","year":"2006","unstructured":"Coffey JC, Wang JH, Bouchier-Hayes D, Cotter TG, Redmond HP. The targeting of phosphoinositide-3 kinase attenuates pulmonary metastatic tumor growth following laparotomy. Ann Surg. 2006;243:250\u20136.","journal-title":"Ann Surg"},{"key":"3306_CR57","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1097\/SLA.0b013e3181efc635","volume":"252","author":"O Al-Sahaf","year":"2010","unstructured":"Al-Sahaf O, Wang JH, Browne TJ, Cotter TG, Redmond HP. Surgical injury enhances the expression of genes that mediate breast cancer metastasis to the lung. Ann Surgery. 2010;252:1037\u201343.","journal-title":"Ann Surgery"},{"key":"3306_CR58","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/JTO.0b013e31824a9022","volume":"7","author":"R Demicheli","year":"2012","unstructured":"Demicheli R, Fornili M, Ambrogi F, Higgins K, Boyd JA, Biganzoli E, et al. Recurrence dynamics for non-small-cell lung cancer: effect of surgery on the development of metastases. J Thorac Oncol. 2012;7:723\u201330.","journal-title":"J Thorac Oncol"},{"key":"3306_CR59","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.critrevonc.2013.07.008","volume":"89","author":"W Ceelen","year":"2014","unstructured":"Ceelen W, Pattyn P, Mareel M. Surgery, wound healing, and metastasis: recent insights and clinical implications. Crit Rev Oncol Hematol. 2014;89:16\u201326.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3306_CR60","doi-asserted-by":"crossref","unstructured":"Shurin MR, Baraldi JH, Shurin GV. Neuroimmune regulation of surgery-associated metastases. Cells. 2021;10:454.","DOI":"10.3390\/cells10020454"},{"key":"3306_CR61","doi-asserted-by":"crossref","unstructured":"Baghaie L, Haxho F, Leroy F, Lewis B, Wawer A, Minhas S, et al. Contemporaneous perioperative inflammatory and angiogenic cytokine profiles of surgical breast, colorectal, and prostate cancer patients: clinical implications. Cells. 2023;12:2767.","DOI":"10.3390\/cells12232767"},{"key":"3306_CR62","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.cllc.2013.01.002","volume":"14","author":"CR Kelsey","year":"2013","unstructured":"Kelsey CR, Fornili M, Ambrogi F, Higgins K, Boyd JA, Biganzoli E, et al. Metastasis dynamics for non-small-cell lung cancer: effect of patient and tumor-related factors. Clin Lung Cancer. 2013;14:425\u201332.","journal-title":"Clin Lung Cancer"},{"key":"3306_CR63","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1093\/ejcts\/ezv462","volume":"49","author":"K Watanabe","year":"2016","unstructured":"Watanabe K, Tsuboi M, Sakamaki K, Nishii T, Yamamoto T, Nagashima T, et al. Postoperative follow-up strategy based on recurrence dynamics for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2016;49:1624\u201331.","journal-title":"Eur J Cardiothorac Surg"},{"key":"3306_CR64","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s11538-017-0388-9","volume":"80","author":"L Hanin","year":"2018","unstructured":"Hanin L, Rose J. Suppression of metastasis by primary tumor and acceleration of metastasis following primary tumor resection: a natural law? Bull Math Biol. 2018;80:519\u201339.","journal-title":"Bull Math Biol"},{"key":"3306_CR65","doi-asserted-by":"crossref","unstructured":"Benzekry S, Gandolfi A, Hahnfeldt P. Global dormancy of metastases due to systemic inhibition of angiogenesis. PLoS ONE. 2014;9:e84249.","DOI":"10.1371\/journal.pone.0084249"},{"key":"3306_CR66","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/bjc.1996.335","volume":"74","author":"M Franco","year":"1996","unstructured":"Franco M, Bustuoabad OD, di Gianni PD, Goldman A, Pasqualini CD, Ruggiero RA. A serum-mediated mechanism for concomitant resistance shared by immunogenic and non-immunogenic murine tumours. Br J Cancer. 1996;74:178\u201386.","journal-title":"Br J Cancer"},{"key":"3306_CR67","doi-asserted-by":"crossref","unstructured":"Montagna DR, Duarte A, Chiarella P, Rearte B, Bustuoabad OD, Vermeulen M, et al. Inhibition of hyperprogressive cancer disease induced by immune-checkpoint blockade upon co-treatment with meta-tyrosine and p38 pathway inhibitor. BMC Cancer. 2022;22:845.","DOI":"10.1186\/s12885-022-09941-2"},{"key":"3306_CR68","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00383-024-05788-9","volume":"40","author":"K Mimura","year":"2024","unstructured":"Mimura K, Fumino S, Yamashi K, Iguchi M, Inoue M, Takayama S, et al. Systemic inflammation enhances metastatic growth in a syngeneic neuroblastoma mouse model. Pediatr Surg Int. 2024;40:195.","journal-title":"Pediatr Surg Int"},{"key":"3306_CR69","doi-asserted-by":"crossref","unstructured":"Devaud C, John LB, Westwood JA, Yong CSM, Beavis PA, Schwendener RA, et al. Cross-talk between tumors can affect responses to therapy. Oncoimmunology. 2015;4:e975572.","DOI":"10.1158\/2326-6074.CRICIMTEATIAACR15-A105"},{"key":"3306_CR70","doi-asserted-by":"crossref","unstructured":"Bordonaro M, Lazarova D. Hypothesis: cancer hormesis and its potential for cancer therapeutics. Life (Basel). 2024;14:401.","DOI":"10.3390\/life14030401"},{"key":"3306_CR71","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s12185-011-0799-6","volume":"93","author":"T Yaguchi","year":"2011","unstructured":"Yaguchi T, Sumimoto H, Kudo-Saito C, Tsukamoto N, Ueda R, Iwata-Kajihara T, et al. The mechanisms of cancer immunoescape and development of overcoming strategies. Int J Hematol. 2011;93:294\u2013300.","journal-title":"Int J Hematol"},{"key":"3306_CR72","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1126\/science.1203486","volume":"331","author":"RD Schreiber","year":"2011","unstructured":"Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion. Science. 2011;331:1565\u201370.","journal-title":"Science"},{"key":"3306_CR73","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nri3789","volume":"15","author":"T Kitamura","year":"2015","unstructured":"Kitamura T, Qian BZ, Pollard JW. Immune cell promotion of metastasis. Nat Rev Immunol. 2015;15:73\u201386.","journal-title":"Nat Rev Immunol"},{"key":"3306_CR74","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"3306_CR75","first-page":"4770","volume":"59","author":"P Hahnfeldt","year":"1999","unstructured":"Hahnfeldt P, Panigrahy D, Folkman J, Hlatky L. Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. Cancer Res. 1999;59:4770\u20135.","journal-title":"Cancer Res"},{"key":"3306_CR76","doi-asserted-by":"crossref","unstructured":"Zahid MU, Mohamed ASR, Caudell JJ, Harrison LB, Fuller CD, Moros EG, et al. Dynamics-adapted radiotherapy dose (dard) for head and neck cancer radiotherapy dose personalization. J Pers Med. 2021;11:1124.","DOI":"10.3390\/jpm11111124"},{"key":"3306_CR77","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.ijrobp.2021.05.132","volume":"111","author":"MU Zahid","year":"2021","unstructured":"Zahid MU, Mohsin N, Mohamed ASR, Caudell JJ, Harrison LB, Fuller CD, et al. Forecasting individual patient response to radiation therapy in head and neck cancer with a dynamic carrying capacity model. Int J Radiat Oncol Biol Phys. 2021;111:693\u2013704.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3306_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108589","volume":"27","author":"TE Yankeelov","year":"2024","unstructured":"Yankeelov TE, Hormuth DA 2nd, Lima E, Lorenzo G, Wu C, et al. Designing clinical trials for patients who are not average. iScience. 2024;27:108589.","journal-title":"iScience"},{"key":"3306_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.mbs.2024.109287","volume":"376","author":"KR Scibilia","year":"2024","unstructured":"Scibilia KR, Schlicke P, Schneller F, Kuttler C. Predicting resistance and pseudoprogression: are minimalistic immunoediting mathematical models capable of forecasting checkpoint inhibitor treatment outcomes in lung cancer? Math Biosci. 2024;376:109287.","journal-title":"Math Biosci"},{"key":"3306_CR80","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41746-025-01579-1","volume":"8","author":"C Wu","year":"2025","unstructured":"Wu C, Lima E, Stowers CE, Xu Z, Yam C, Son JB, et al. MRI-based digital twins to improve treatment response of breast cancer by optimizing neoadjuvant chemotherapy regimens. npj Digit Med. 2025;8:195.","journal-title":"npj Digit Med"},{"key":"3306_CR81","doi-asserted-by":"crossref","unstructured":"Walker R, Poleszczuk J, Pilon-Thomas S, Kim S, Anderson ARA, Czerniecki BJ, et al. Immune interconnectivity of anatomically distant tumors as a potential mediator of systemic responses to local therapy. Sci Rep. 2018;8:9474.","DOI":"10.1038\/s41598-018-27718-1"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03306-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03306-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03306-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T10:02:25Z","timestamp":1774864945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03306-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":81,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,4,20]]}},"alternative-id":["3306"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03306-9","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RI is an inventor listed on several nanoparticle patents. All patents are assigned to Aduro Biosciences, Inc or The Johns Hopkins University. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}